Antimelanogenic Effect of Taurine in Murine Melanoma B16F10 Cells

B16F10 Murine Melanoma 세포에서 멜라닌생성억제에 대한 타우린의 효과

  • 정효숙 (숙명여자대학교 약학대학) ;
  • 송경희 (숙명여자대학교 약학대학) ;
  • 김안근 (숙명여자대학교 약학대학)
  • Published : 2007.10.31

Abstract

Taurine has been shown to be tissue-protective against oxidant-induced injury and is a powerful regulator of the immune system. However, there is no study on the antimelanogenic effect of taurine. In this study, we investigated the whitening effect of taurine in B16F10 mouse melanoma cells. Cell viability was measured by MTT assay. We examined melanin contents and tyrosinase activity according to time and concentration. Extracellular signal regulated kinase (ERK) is an important regulator of melanogenesis. It has been reported that activated ERK induced microphthalmia associated transcription factor (MITF) phosphorylation and its subsequent degradation and thus reduced melanin synthesis. In our B16F10 cell culture system, taurine led to decrease melanin contents by 21% at 48 hr. We then observed taurine effects on ERK-P, MITF and tyrosinase by Western blot. ERK was activated at 18 hr and 24 hr, whereas MITF reduced. We could not observe any differences in the levels of tyrosinase. These results suggested that taurine inhibited melanogenesis by ERK signal pathway via MITF degradation. We expect that taurine has potential skin whitening agents in cosmetics.

Keywords

References

  1. Park, E. K. and Schuller-Levis, G. B : Taurine : new implication for an old amino acid. FEMS Microbiol. Lett. 226, 195 (2003) https://doi.org/10.1016/S0378-1097(03)00611-6
  2. Choray, M., Kontny, E., Marcinkiewicz, J. and Maslinski, W. : Taurine chloramine modulates cytokine production by human peripheral blood mononuclear cells. Amino Acids 23, 407 (2002)
  3. Georgia, B., Schuller-Levis, and Eunkyue Park, E. K.: Taurine and Its Chloramine: Modulators of Immunity. Neurochem Res. 29(1), 117 (2004) https://doi.org/10.1023/B:NERE.0000010440.37629.17
  4. Ibrahim, S. M., Koczan, D. and Thiesen, H. J. : Gene-expression profile of collagen-induced arthritis. J. Autoimmun. 18, 159 (2002)
  5. Baura, M., Liu, Y. and Quinn, M. R. : Taurine chloramine inhibits inducible nitric oxide synthase and $TNF-{\alpha}$ gene expression in activated alveolar macrophages : Decreased NF-kB activation and IkB kinase activity. J. Immunol. 167, 2275 (2002)
  6. Parcell, S. : Sulfur in human nutrition and applications in medicine. Altern. Med. Rev. 7, 22 (2002)
  7. Sturman, J. A.: Taurine in development. Physical Rev. 73, 119 (1993)
  8. Englaro, W., Bertolotto, C, Busca, R., Brunet, A., Pages, G., Ortonne, J. P. and Ballotti, R. : Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation. J. Biol Chem. 273, 9966 (1998)
  9. Kim, D. S., Hwang, E. S., Lee, J. E., Kim, S. Y., Kwon, S. B. and Park, K. C. : Sphingosin-1-phophate decrease melanin synthesis via sustained ERK activation and subsequent MITF degradation. J. Cell Sci. 116, 1699 (2003) https://doi.org/10.1242/jcs.00366
  10. Kim, D. S., Kim, S. Y., Chung, J. H., Kim, K. H., Eun, H. C. and Park, K. C. : Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes. Cell Signal. 14, 779 (2002)
  11. Englaro, W., Rezzonico, R., Durand-Clement, M., Lallemand, D., Ortonne, J. P. and Ballotti, R. : Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J. Biol. Chem. 270, 24315 (1995)
  12. Kim, D. S., Park, S. H. and Park, K. C. : Transforming growth $factor-{\beta}1$ decreases melanin synthesis via delayed extracellular signal-regulated kinase activation. Int. J. Biochem. Cell Biol. 36, 1482 (2004)
  13. Kim, D. S., Park, S. H., Kwon, S. B., Na, J. I., Huh, C. H. and Park, K. C.: Additive effects of heat and p38 MAPK inhibitor treatment on melanin synthesis. Arch. Pharm. Res. 30(3), 581 (2007) https://doi.org/10.1007/BF02977652
  14. Roser, B. and Robert, B.: Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment. Cell Res. 13, 60 (2000)
  15. Bertolotto, C, Busca, R., Abbe, P., Bille, K., Aberdam, E. and Ortonne, J. P. et al.: Different cis-acting elements are involved in the regulation of TRP1 and promoter activities by cyclic AMP: Pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol. 18, 694 (1998)
  16. Vistica, D. T., Skehan, R, Scudiero, D., Monks, A., Pittman, A. and Boyd, M. R. : Tetrasodium-based assays for cellular viability a critical examination of selected parameters affecting formazan production. Cancer Res. 51, 2515 (1991)
  17. Martinez-Esparza, M., Jimenez-Cervantes, C., Beermann, F., Aparicio, P., Lozano, J. A. and Garcia-Borron, J. C. : Transforming growth factor-betal inhibits basal melanogenesis in B16/F10 mouse melanoma cells by increasing the rate of degradation of tyrosinase and tyrosinase-related protein-1. J. Biol. Chem. 272, 3967 (1997)
  18. Martinez-Esparza, M., Ferrer, C., Castells, M. T., Garcia-Borron, J. C. and Zuasti, A. : Transforming growth factor beta 1 mediates hypopigmentation of B16 mouse melanoma cells by inhibition of melanin formation and melanosome maturation. Int. J. Biochem. Cell Biol. 33, 971 (2001)
  19. Busca, R., Abbe, E, Mantoux. E, Aberdam, E., Eychene, A., Ortonne, J. P. and Ballotti, R. : B-Raf mediates the cAMP activation of MAPK in B16 melanoma cells. Pigment Cell Res. Suppl 7, 106 (1999)
  20. Yavuzer, U., Keenan, E., Lowings, P., Vachtenheim, J., Currie, G. and Goding, C. R. : The microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription. Oncogene 10, 123 (1995)